hSyn-IRES2-GFP
(Plasmid
#234875)
-
PurposeLentiviral plasmid with a multiple cloning site followed by IRES2-GFP.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 234875 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonelenti SYN-FLAG-dCas9-VPR
-
Backbone manufacturerJeremy Day (Addgene #114196)
- Backbone size w/o insert (bp) 8573
- Total vector size (bp) 9339
-
Modifications to backboneInserted IRES2 site before EGFP
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameEGFP
-
Insert Size (bp)720
- Promoter hSYn
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer ctgcctcagtctgcggtg
- 3′ sequencing primer cttgcttcctttggcgag (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byDidier Trono (GFP amplified from Addgene #12252) and Pamela McLean (IRES site amplified from CIGW vector described in St. Martin et al., 2007; https://doi.org/10.1111/j.1471-4159.2006.04310.x)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
hSyn-IRES2-GFP was a gift from Andrew Arrant (Addgene plasmid # 234875 ; http://n2t.net/addgene:234875 ; RRID:Addgene_234875) -
For your References section:
Delivering progranulin to neuronal lysosomes protects against excitotoxicity. Davis SE, Roth JR, Aljabi Q, Hakim AR, Savell KE, Day JJ, Arrant AE. J Biol Chem. 2021 Sep;297(3):100993. doi: 10.1016/j.jbc.2021.100993. Epub 2021 Jul 21. 10.1016/j.jbc.2021.100993 PubMed 34298019